Related Experiment Video
Updated: Oct 5, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Population attributable fractions of modifiable cancer risk factors in Korea: a systematic review protocol
Mi Ah Han1, Eu Chang Hwang2, Jae Hung Jung3,4
1Department of Preventive Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea mahan@chosun.ac.kr.
Introduction:
The burden of cancer continues to increase worldwide, and cancer is the leading cause of life expectancy reduction and death in Korea. Population attributable fraction (PAF), an epidemiological measure of exposures and health outcomes, could provide information on the public health impacts of exposures in populations. Knowing the PAFs of modifiable risk factors could aid in planning and prioritising strategies to reduce cancer burden in the population. This study aims to summarise systematically the PAF estimates of modifiable cancer risk factors in Korea.
Methods And Analysis:
This review will include studies that determined PAFs of modifiable risk factors on cancer incidence and mortality in Korea. We will define modifiable risk factors as those that can be changed directly by peoples' conscious actions. We will perform systematic searches in EMBASE, MEDLINE, Cochrane Library and Korean databases (Korean Studies Information Service System, Research Information Sharing Service, KoreaMED, Korean Medical Database, National Assembly Library, and Korea Institute of Science and Technology Information) from their inception to July 2021. Two reviewers will independently screen studies for eligibility, extract data and perform quality assessments of the included studies. We will present the results in a qualitative or descriptive manner and will not perform meta-analyses or other quantitative data synthesis to derive summary estimates of PAFs because we anticipate high variability among PAF estimates.
Ethics And Dissemination:
Ethics approval is not required because we will only use data from published papers. We will disseminate the results through publication in a peer-reviewed journals.
Prospero Registration Number:
CRD42021268258.
Related Concept Videos
Cancer Prevention
Some...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer Survival Analysis
Statistical Methods for Analyzing Epidemiological Data
Mutagenicity and Carcinogenicity
Hazard Ratio
For example, in a clinical trial...

